{"title":"Peripapillary nerve fiber layer in patients with iron-deficiency anemia: A cross-sectional study at a tertiary eye care center in Central India.","authors":"Rajesh Subhash Joshi, Rajesh Namdeo Ingle","doi":"10.4103/ojo.ojo_229_23","DOIUrl":"10.4103/ojo.ojo_229_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"306-307"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Chronic dacryocystitis: An insight into bacteriology and antimicrobial sensitivity pattern.","authors":"Vibhuti Sethi, Himanshu Kumar Mittal, Rajeev Tuli","doi":"10.4103/ojo.ojo_116_23","DOIUrl":"10.4103/ojo.ojo_116_23","url":null,"abstract":"<p><strong>Context: </strong>Adequate management of chronic dacryocystitis is an essential prerequisite before any intraocular surgery owing to a grave risk of endophthalmitis. The knowledge of bacteriology of chronic dacryocystitis would accentuate the choice of effective antimicrobial agents and thus help in reducing the irrational use of antimicrobial agents and subsequent development of drug resistance.</p><p><strong>Aims: </strong>We aimed to identify the causative bacterial flora and study the antimicrobial sensitivity and resistance pattern in cases of chronic dacryocystitis.</p><p><strong>Settings and design: </strong>This was a cross-sectional observational study.</p><p><strong>Subjects and methods: </strong>Conjunctival swabs were obtained from both eyes from 102 patients with clinical evidence of chronic dacryocystitis. Specimens for microbiological analysis were obtained, either from the conjunctival cul-de-sac and everted puncta by applying pressure over the lacrimal sac area or from the refluxing material after irrigating the lacrimal sac with sterile saline. The specimens were sent for culture and sensitivity in the department of microbiology. Ethical approvals were duly obtained.</p><p><strong>Statistical analysis used: </strong>Percentage assessment was used for statistical analysis.</p><p><strong>Results: </strong>The cultures showed the presence of <i>Staphylococcus aureus</i> in 50% of bacterial isolates obtained from the involved eyes, followed by coagulase-negative <i>Staphylococcus</i> in 11.53% of isolates and <i>Enterococcus</i> also in 11.53% of isolates. It was observed that cefoxitin was the most sensitive antibiotic against Gram-positive organisms, followed by vancomycin and clindamycin, whereas maximum resistance was seen for penicillin and ofloxacin. For Gram-negative organisms, imipenem was found to be most sensitive, followed by gentamicin and co-amoxiclav, whereas maximum resistance was seen for ciprofloxacin.</p><p><strong>Conclusions: </strong>It was concluded that Gram-positive bacteria predominantly <i>S.</i> <i>aureus</i> was the most commonly isolated bacteria in cases of chronic dacryocystitis as compared to Gram-negative bacteria and cefoxitin was found to be the overall most effective antibiotic for Gram-positive bacteria.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"192-197"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Manifestations of COVID-19 in the posterior eye segment - Up-to-date.","authors":"Basheer Abdullah Marzoog","doi":"10.4103/ojo.ojo_212_22","DOIUrl":"10.4103/ojo.ojo_212_22","url":null,"abstract":"<p><p>Since coronavirus disease infection-19 (COVID-19) entry to the cells is angiotensin enzyme receptor (ACEII) dependent, extrapulmonary manifestations have been suspected. Ocular manifestations reported in several studies to involve the anterior as well as posterior eye segments. However, the predominance of the anterior eye segment reduced the attention of the scientific community on the posterior eye segment. Our results showed that the incidence of changes in the posterior eye segment is 1/5 of the anterior eye segment. Posterior eye segment manifestations include acute macular neuroretinopathy and paracentral middle maculopathy, central retinal vein/artery occlusion, reactivation of previous uveitis, varicella zoster virus-related acute retinal necrosis in an immunocompromised patient, chorioretinitis, macular hemorrhage, paracentral acute middle maculopathy, retinal detachment, and vitritis with outer retinal abnormalities. The pathogenesis of posterior eye segment manifestations under COVID-19 includes viremia, autoimmune vasculitis, hyperimmune response, coagulopathy, and cytokine storm. A full ophthalmological examination is crucial for patients recovering from COVID-19. The paper provided up-to-date manifestations with potential underlying pathophysiological mechanisms of development, as well as pathogenetic therapy.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"166-172"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy and safety of large-scale use of vancomycin injection in infusion bottle during vitreoretinal procedures.","authors":"Subhendu Kumar Boral, Deepak Agarwal, Arnab Das, Debdulal Chakraborty, Santanu Mandal, Tushar Kanti Sinha","doi":"10.4103/ojo.ojo_39_24","DOIUrl":"10.4103/ojo.ojo_39_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess the safety and efficacy of large-scale use of vancomycin injection in an infusion bottle during vitreoretinal procedures.</p><p><strong>Materials and methods: </strong>This was a retrospective evaluation of all vitreoretinal procedures done in the last 70 months, where intraoperatively vancomycin injection (0.2 mg/mL) was used in an infusion bottle prophylactically as standard care. Vitreoretinal procedures were categorized as major (duration >30 min), minor (duration <30 min), and silicone oil removal. Postoperatively, a detailed ocular examination was done to rule out hemorrhagic occlusive retinal vasculitis (HORV) or signs of postoperative bacterial endophthalmitis.</p><p><strong>Results: </strong>Over the last 70 months, a total of 31,720 vitreoretinal procedures were performed, which included 24,371 major vitreoretinal procedures, 1401 minor vitreoretinal procedures, and 5948 silicone oil removal cases. None of these cases developed HORV or bacterial endophthalmitis.</p><p><strong>Conclusion: </strong>Vancomycin (0.2 mg/mL) in infusion fluid during vitreoretinal procedures is safe and can be advocated as a prophylactic measure against postvitrectomy bacterial infections.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"234-236"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Syed Wajahat Ali Rizvi, Syed Ali Raza Rizvi, Shagufta Qadri, Saifullah Khalid, Mohammed Azfar Siddiqui, Adeeb Alam Khan, Afeefa Akhter
{"title":"Orbital malignant peripheral nerve sheath tumor: A case report and review.","authors":"Syed Wajahat Ali Rizvi, Syed Ali Raza Rizvi, Shagufta Qadri, Saifullah Khalid, Mohammed Azfar Siddiqui, Adeeb Alam Khan, Afeefa Akhter","doi":"10.4103/ojo.ojo_299_23","DOIUrl":"10.4103/ojo.ojo_299_23","url":null,"abstract":"<p><p>Malignant peripheral nerve sheath tumor of the orbit is an exceedingly rare entity. These tumors exhibit locally aggressive behavior, recurrences, distant metastasis, and poor response to existing treatment protocols. Orbital nerve sheath tumors are often associated with neurofibromatosis 1, and malignant transformation of neurofibroma into malignant nerve sheath tumor has also been seen. The recommended treatment for localized disease is radical or wide surgical excision to achieve negative margins followed by chemoradiation. For extensive disease, chemotherapy and radiotherapy can be utilized to stabilize the disease. Due to poor response and outcomes with current regimens, the focus has been shifted to approaches utilizing molecular targets and immunological agents. Despite all the advancements, the outcomes still remain discouraging for moderate- to high-grade lesions and thus necessitate studies to design promising treatment modalities.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"254-260"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shreesha Kumar Kodavoor, B Soundarya, Ramamurthy Dandapani
{"title":"Outcomes of deep anterior lamellar keratoplasty in eyes with healed hydrops - A retrospective interventional analysis.","authors":"Shreesha Kumar Kodavoor, B Soundarya, Ramamurthy Dandapani","doi":"10.4103/ojo.ojo_242_22","DOIUrl":"10.4103/ojo.ojo_242_22","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the study was to analyze the techniques and outcomes of deep anterior lamellar keratoplasty (DALK) done in eyes with healed hydrops.</p><p><strong>Methods: </strong>Thirty-one eyes with paracentral scars following acute hydrops underwent DALK and were included in the study. Manual layer-by-layer dissection with stromal air injection was done in all cases, keeping dissection of the site of preexisting perforation to the end.</p><p><strong>Results: </strong>Out of the 31 eyes, in 28 eyes, DALK could be completed, and in 3 eyes, procedure had to be converted to penetrating keratoplasty. Visual outcomes in all cases were good, with 26 out of 28 eyes (92.8%) achieving a best-corrected visual acuity (BCVA) of 6/12 or better. Preoperative mean BCVA of LogMAR 1.19 ± 0.27 improved to a postoperative mean BCVA of LogMAR 0.23 ± 0.08 (<i>P</i> < 0.00001). Postoperative mean refractive astigmatism at the last follow-up was -2.69 ± 0.82 D with postoperative a spherical equivalent of -2.31 ± 0.7 D. Complications included double anterior chamber in one eye and secondary angle closure in two eyes. Stromal rejection in one eye was managed with steroids and one eye with suture infiltrate needed selective suture removal.</p><p><strong>Conclusion: </strong>Layer-by-layer dissection with limited air injection into the stroma has shown good visual outcomes in patients undergoing DALK following healed hydrops, and DALK can very well be the primary treatment option even in such cases with a paracentral posthydrops scar.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"210-213"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abhishek Das, Prema Subramaniam, Parag K Shah, Venkatapathy Narendran
{"title":"Spontaneous appearance and resolution of vitreous hemorrhage after bevacizumab injection in retinopathy of prematurity.","authors":"Abhishek Das, Prema Subramaniam, Parag K Shah, Venkatapathy Narendran","doi":"10.4103/ojo.ojo_58_23","DOIUrl":"10.4103/ojo.ojo_58_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"293-295"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Boergen modification of Harada-ito surgery with and without vertical muscle surgery for acquired unilateral superior oblique muscle palsy.","authors":"Hajar Farvardin, Hadi Farvardin, Majid Farvardin","doi":"10.4103/ojo.ojo_183_23","DOIUrl":"10.4103/ojo.ojo_183_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose is to report the results of the Boergen modification of the Harada-Ito procedure with and without simultaneous vertical muscle surgery in patients with acquired unilateral superior oblique muscle palsy.</p><p><strong>Patients and methods: </strong>Files of patients with acquired unilateral superior oblique muscle palsy who were treated with Boergen modification of the Harada-Ito procedure were studied retrospectively. For each patient, age at the time of surgery, the presence of diplopia, compensatory head posture, and ocular deviation before and after surgery were retrieved. Results were evaluated 6 months after surgery.</p><p><strong>Results: </strong>A total of 12 patients with a mean age of 32 years at the time of surgery (range 15-45 years) were included. The underlying etiology was head trauma in eleven patients. The modified Harada-Ito procedure alone was done for three cases (Group 1), and a simultaneous combination of this procedure and vertical muscle surgery was performed in nine patients (Group 2). The average intorsional effect in the primary position was 9.2° (8° in Group 1 and 9.6° in Group 2). The average correction of hypertropia in the primary position was 8.2 prism diopters (PD) (1 PD in Group 1 and 10.6 PD in Group 2). Diplopia in the primary position and downgaze were resolved in eleven patients and ten patients, respectively. Four patients had a compensatory head tilt at their last follow-up.</p><p><strong>Conclusions: </strong>Boergen modification of the Harada-Ito procedure, alone and combined with vertical muscle surgery, successfully corrected primary position diplopia in the majority of the patients.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"214-218"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Conjunctival nodule as a primary manifestation of disseminated histoplasmosis.","authors":"Chhavi Gupta Narula, Arpan Gandhi, Sima Das","doi":"10.4103/ojo.ojo_158_23","DOIUrl":"10.4103/ojo.ojo_158_23","url":null,"abstract":"<p><p>Histoplasmosis is a granulomatous infection caused by dimorphic fungus-<i>Histoplasma capsulatum</i>. Ocular involvement is mainly in the form of retinal or choroidal involvement as presumed ocular histoplasmosis mostly in immunocompromised patients. Conjunctival, scleral, and adnexal involvement is rarely reported. We report a case of disseminated histoplasmosis with conjunctival lesion as the initial clinical manifestation clinching the diagnosis.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 2","pages":"275-277"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11309541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}